M

MGI Tech Co Ltd
SSE:688114

Watchlist Manager
MGI Tech Co Ltd
SSE:688114
Watchlist
Price: 48.81 CNY -2.03% Market Closed
Market Cap: 20.3B CNY
Have any thoughts about
MGI Tech Co Ltd?
Write Note

MGI Tech Co Ltd
Accrued Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

MGI Tech Co Ltd
Accrued Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Accrued Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
M
MGI Tech Co Ltd
SSE:688114
Accrued Liabilities
ÂĄ310.1m
CAGR 3-Years
0%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
WuXi AppTec Co Ltd
SSE:603259
Accrued Liabilities
ÂĄ2.2B
CAGR 3-Years
10%
CAGR 5-Years
26%
CAGR 10-Years
N/A
Pharmaron Beijing Co Ltd
SZSE:300759
Accrued Liabilities
ÂĄ732.6m
CAGR 3-Years
17%
CAGR 5-Years
28%
CAGR 10-Years
N/A
WuXi Biologics (Cayman) Inc
HKEX:2269
Accrued Liabilities
ÂĄ393.2m
CAGR 3-Years
-1%
CAGR 5-Years
28%
CAGR 10-Years
N/A
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
Accrued Liabilities
ÂĄ346m
CAGR 3-Years
25%
CAGR 5-Years
28%
CAGR 10-Years
46%
W
WuXi XDC Cayman Inc
HKEX:2268
Accrued Liabilities
ÂĄ74.9m
CAGR 3-Years
109%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

MGI Tech Co Ltd
Glance View

Market Cap
20.1B CNY
Industry
Life Sciences Tools & Services

MGI Tech Co., Ltd. engages in the research and development, production, and sale of DNA sequencing instruments, reagents, and related products to support life science research, agriculture, precision medicine and healthcare. The company is headquartered in Shenzhen, Guangdong and currently employs 2,805 full-time employees. The company went IPO on 2022-09-09. The firm is mainly engaged in three businesses. The gene sequencer business mainly includes the development of small and medium-sized desktop sequencers and large and ultra-large sequencers, and the establishment of a full range of multi-model product matrix to meet the needs of users in different application scenarios. The laboratory automation business mainly includes the development of automated sample processing systems, laboratory automation pipelines, sample processing reagent consumables and other laboratory automation products. The new business mainly includes cytomic solutions, remote ultrasound robots and bioinformation Technology (BIT) products.

Intrinsic Value
44.8 CNY
Overvaluation 8%
Intrinsic Value
Price
M

See Also

What is MGI Tech Co Ltd's Accrued Liabilities?
Accrued Liabilities
310.1m CNY

Based on the financial report for Dec 31, 2023, MGI Tech Co Ltd's Accrued Liabilities amounts to 310.1m CNY.

What is MGI Tech Co Ltd's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 3Y
0%

Over the last year, the Accrued Liabilities growth was -18%.

Back to Top